R&D Partner Content 5th mRNA-Based Therapeutics Summit Europe The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
R&D Partner Content 10th Tumor Models Summit San Francisco Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation meets opportunity
R&D Partner Content Key Trends Shaping the Pharmaceutical Industry at PHARMAP 20... The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 welcomes project leaders, procurement speciali
R&D Partner Content The Future of DDR-Targeted Oncology Starts Here! 9th DDR Inhibitors Summit | January 27–29, 2026 | Boston, MA
R&D Partner Content The Future of Patient-Centric Access is Here! 6th Operationalize: Expanded Access Programs Summit | March 24-26, 2026 | Boston, MA
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.